Updates from FDA’s Office of Prescription Drug Promotion: Standards for Direct-to-Consumer Advertising Read more
FDA Releases Draft Guidance on Randomized Controlled Drug Trials in Routine Clinical Practice Read more
Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating Cancer Drug Efficacy Read more